CapDecisif holds first close for CapDecisif 4

The VC is aiming to exceed its €50m target but not surpass the €70m assigned hard-cap. No placement agent was used for the fundraising. 

The new vehicle represents an increase on the fund size of its predecessor CapDecisif 3, which closed on €45m in January 2012.

Investors 
CapDecisif 4’s main backer is BPI France, which invested via the Fonds National d’Amorçage 1. Other institutional investors include historical partners BNP Paribas and Caisse d’Epargne Ile-de-France. Family office Pradeyrol Développement and business angels also made commitments to the vehicle. 

Cornerstone corporate investors at first close include Philips and cosmetic group L’Occitane. Moreover, Daniel Caille, the president of private hospitals group Vivalto Santé, is backing CapDecisif 4 via his family office business Vivalto.

The firm has simultanousely established E-Health 360°, a dedicated think-tank in which corporates acting as LPs for the vehicle can review investment opportunities and mentor the vehicle's portfolio companies. 

Investments
CapDecisif 4 focuses on investing in digital health as well as technology and healthcare companies, mostly located in France. The VC will lead or co-lead seed rounds and follow-on financings.

The VC provides tickets in the €500,000-1.5m range and can commit up to €5m to a business. 

People
CapDecisif - Jérôme Snollaerts (managing partner, CEO), Catherine Boule (managing partner), Baudouin Hue (investment director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Funds
• Venture
• France
• Technology
• Healthcare
• France
• Venture